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Abstract
Objective—Sleep apnea (SA) has been linked with various forms of cardiovascular disease, but 
little is known about its association with peripheral artery disease (PAD) measured using the 
ankle- brachial index (ABI). This relationship was evaluated in the Hispanic Community Health 
Study/Study of Latinos (HCHS/SOL).
Approach and Results—We studied 8,367 HCHS/SOL participants who were 45 to 74 years 
of age. Sleep symptoms were examined with the self-reported Sleep Health Questionnaire. SA was 
assessed using an in-home sleep study. Systolic blood pressure was measured in all extremities to 
compute the ABI. PAD was defined as ABI < 0.90 in either leg. Multivariable logistic regression 
was utilized to investigate the association between moderate-to-severe SA, defined as apnea-
hypopnea index (AHI) ≥15, and the presence of PAD. Analyses were adjusted for covariates.
The prevalence of PAD was 4.7% (n=390). The mean AHI was significantly higher among adults 
with PAD compared to those without (11.1 vs. 8.6 events/hour, p=0.046). After adjusting for 
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covariates, moderate-to-severe SA was associated with a 70% increase in the odds of PAD (odds 
ratio 1.7, 95% CI: 1.1 – 2.5, p=0.0152). This association was not modified by sex (p=0.8739). 
However, there was evidence that the association between moderate-to-severe SA and PAD varied 
by Hispanic/Latino background (p < 0.01). Specifically, the odds were stronger in Mexican 
(adjusted OR 2.9, 95% CI: 1.3, 6.2) and in Puerto Rican Americans (adjusted OR 2.0, 95% CI: 
0.97 – 4.2) than in other backgrounds.
Conclusions—Moderate-to-severe SA is associated with higher odds of PAD in Hispanic/
Latino adults.
Keywords
Sleep apnea; peripheral arterial disease; ankle-brachial index; subclinical atherosclerosis; US 
Hispanics and Latinos
Introduction
We recently reported the prevalence of mild, moderate and severe sleep apnea (SA) in the 
U.S. Hispanic/Latino population to be 25.8, 9.8, and 3.9%, respectively.1 SA occurs when 
the upper airway collapses during sleep resulting in a cycle of hypoxemia, increased 
respiratory effort, frequent arousals, and increased sympathetic activity. The apnea–
hypopnea index (AHI) is calculated as the sum of apneas and hypopneas per hour of sleep. 
Clinically significant SA is considered to be of at least moderate severity, defined as AHI 
≥15 per hour.
SA is associated with cardiovascular morbidity and mortality and is an independent risk 
factor for coronary artery disease and stroke.2–4 Atherosclerosis has been proposed as an 
intermediate between SA and incident cardiovascular disease events.5 Numerous studies5–22 
have explored the relationship between SA and measures of atherosclerotic vascular disease 
in clinical or population-based samples. Such studies have examined the endpoint of carotid 
artery intima-media thickness and reported a significant positive association between SA 
and increased carotid artery intima-media thickness.5,10–13,15–17,21,23,24 Importantly, to our 
knowledge, no study to date has investigated the association between SA and the ankle-
brachial index (ABI), an indicator of significant obstructive peripheral atherosclerotic 
burden in the lower extremities that independently predicts mortality.25
To address the limitations of the current literature, we evaluated the association between SA 
and PAD among participants enrolled in the Hispanic Community Health Study/Study of 
Latinos (HCHS/SOL). We also assessed the role of sex and Hispanic/Latino groups defined 
by place of birth or family background as potential effect modifiers of this association.
Material and Methods
Material and methods are available in the online-only Data Supplement.
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Among a total of 16,415 HCHS/SOL participants, those younger than 45 years of age were 
not assessed for ABI, resulting in exclusion of 6,710 participants. Of the remaining 
participants, 1,110 (6.76%) had missing or incomplete SA data, 39 (0.24%) had missing 
ABI data, and 189 (1.15%) had an ABI >1.4 in either or both legs. Therefore, the analytic 
sample for this study consisted of 8,367 individuals.
The overall prevalence of PAD was 4.7% (n=390). Compared to those without PAD, 
participants with PAD were older (mean age 61 vs. 56 years, p<0.0001) and more often 
women (67% vs. 55%; p=0.0001) (Table 1). The mean BMI was not significantly different 
between the two groups. As expected, the prevalence of comorbidities such as hypertension, 
CHD and diabetes were higher in the PAD group compared to the non-PAD group. 
Similarly, 10 and more pack-years of smoking history was more common in the group with 
PAD (39% vs. 24%).
The mean AHI was significantly higher among adults with PAD compared to those without 
PAD (11.1 vs. 8.6 events/hour, p=0.046) (Table 1). However, there was no statistically 
significant difference in self-reported sleep duration, mean baseline oxygen saturation and 
mean sleep time spent with oxygen less than 90% between the two groups (data not shown).
Table 2 shows the odds ratios (OR) from the multivariable model assessing the relationship 
between no to mild SA and moderate to severe SA (AHI≥15) to PAD. After adjusting for 
age, sex, BMI, waist hip ratio, hypertension, CHD, diabetes, dyslipidemia, CRP levels, 
smoking, alcohol use, physical activity, study site, and Hispanic/Latino background, 
individuals with moderate-to-severe SA were 1.67 (95% CI: 1.10– 2.51) times more likely 
to have PAD. This association was not modified by sex (p=0.8739). However, there was 
evidence that the association between moderate-to-severe SA and PAD was different by 
Hispanic/Latino background (p < 0.0001). Specifically, the odds were stronger in Mexican 
(adjusted OR 2.9, 95% CI: 1.3, 6.2) and in Puerto Rican Americans (adjusted OR 2.02, 95% 
CI: 0.97 – 4.2) than in other backgrounds listed in Table 1. The statistical power was 
inadequate to test this in other Hispanic/Latino groups.
Further analyses also assessed the relationship between increasing severity of SA and PAD 
(Table 3). Here, the reference group consisted of individuals with an AHI < 5. Three other 
categories reflecting increasing AHI severity were defined as 5–15 events/hour, 15–30 
events/hour and ≥ 30 events/hour. In an adjusted model, AHI 15–30 (moderate SA) was 
associated with a 90% increase in the odds of PAD as compared with AHI < 5 (OR 1.90, 95 
% CI: 1.15 – 3.14). The OR for AHI≥30, which defines severe SA, was not statistically 
significant but had a wide confidence interval (versus AHI < 5, OR 1.21, 95% CI: 0.62–
2.38).
We conducted a sensitivity analysis that excluded participants with prevalent CHD, and we 
found similar results (data not shown). We also assessed the independent relationship of 
PAD with sleep variables other than AHI. In a multivariate logistic regression model, there 
was no significant association between T90 and lowest oxygen saturation with PAD after 
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adjustment for age, sex, study site, Hispanic background, income, physical activity and CRP 
levels (data not shown).
Discussion
To our knowledge, this is the first study to assess the independent association between SA 
and PAD in a large community based cohort. We studied a diverse sample of Hispanics/
Latinos, representing the largest minority population, residing within the United States. We 
found that the presence of moderate to severe SA was associated with a 67% increase in the 
odds of PAD, as measured by the ABI. These findings are independent of age, sex, BMI, 
waist hip ratio, hypertension, CHD, diabetes, dyslipidemia, CRP levels, smoking, alcohol 
use, physical activity, study site, and Hispanic/Latino background. The magnitude of this 
association was not modified by sex. Further, the odds were stronger in Mexican and Puerto 
Rican Americans than in other backgrounds, reflecting either the play of chance or 
differences in prevalence and severity of these conditions across national backgrounds. No 
increase in risk of PAD was observed until an AHI of 15 was reached.
SA has been associated with numerous cardiovascular conditions including hypertension26, 
coronary heart disease4,27, cardiac arrhythmias28, heart failure29,30, stroke31 and sudden 
death.32 Plausible mechanisms that may contribute to an overall increased vascular risk in 
the setting of OSA include dyslipidemia33, glucose intolerance34, diabetes35, sympathetic 
activation36, systemic inflammation37,38, endothelial dysfunction19,39, oxidative stress40, 
and autonomic dysfunction.41 Our study contributes to the literature linking SA with 
subclinical markers of vascular disease risk, which include several prior studies of the 
coronary and cerebrovascular beds.6,12,18,21,42 SA is associated with increased carotid artery 
atherosclerosis and treatment of SA appears to decrease and reverse carotid artery 
atherosclerosis.43,44 Evidence also suggests that increasing severity of SA is independently 
associated with increased carotid artery plaque burden.12,17,23,42,45 Similarly, current 
evidence suggests an independent link between SA and coronary artery atherosclerosis 
measured both invasively and non-invasively.46–48 However, until the present study similar 
evidence for the association between SA and PAD was lacking.
PAD affects approximately 20% of individuals older than 60 years and can cause disabling 
symptoms due to claudication.49 PAD is a marker of underlying atherosclerosis severity and 
prognosis, which shares many risk factors with SA including hypertension, obesity and 
diabetes.50–52 A small study of patients with severe PAD who were awaiting surgical 
intervention reported a prevalence of undiagnosed SA of 85% (n=70/82).53 This study had 
several limitations including small sample size, lack of population-based study sample and 
representation of the entire spectrum of PAD severity. In our study, PAD was assessed with 
use of the ABI, a non-invasive, reliable, inexpensive and readily available technique that is 
typically used to diagnose subclinical and clinical PAD. More specifically, we used an 
abnormal ABI (<0.90) in either leg to indicate peripheral atherosclerosis which, compared to 
other non- invasive measures of atherosclerosis, typically requires more extensive burden of 
disease.
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The HCHS/SOL assessed SA with an in-home sleep study as opposed to in-lab full night 
attended polysomnography. This approach may modestly underestimate SA severity and 
does not allow assessment of sleep stages, duration and fragmentation. Variation in 
recording times across individuals may have contributed to some misclassification of the 
AHI in cases when REM sleep was not adequately represented. However, we found no 
association between recording time and either AHI or ABI (data not shown). Further, our 
data are cross-sectional and therefore cannot establish a cause-effect relationship between 
SA and PAD. Adjustment for a full range of potential confounders nonetheless does not 
exclude the possibility of residual confounding.
We conducted a sensitivity analysis where we excluded prevalent coronary heart disease 
(CHD) participants and we found similar results (data not shown). SA may therefore be 
associated with PAD independent of prevalent CHD. Our study was not designed to address 
the relative atherosclerotic effect of sleep apnea on different vascular beds, i.e. coronary vs. 
peripheral.
Future work is recommended to understand whether sleep apnea is worse for the peripheral 
arteries than coronary or carotid arteries.
In analyses of the dose response relationship between SA severity and the odds of PAD 
(Table 3), we did not find consistently increasing risk with increasing SA severity. 
Secondary analyses modeling AHI as categorical levels showed that the strongest 
association between SA and PAD was in the moderate SA group (OR 1.90, 95% CI 1.15 – 
3.14). The lack of significant association in the severe SA group may have been due to the 
sample size limitations, which may be clarified in future studies about dose-response 
relationships.
Finally, we noted that Hispanic/Latino group appears to modify the relationship between SA 
and PAD, with stronger effects for Mexicans and Puerto Ricans relative to other 
backgrounds (listed in Table 1). In our sample, Puerto Ricans had the highest prevalence of 
obesity (50.2%, S.E. 2.32) when compared to the other Hispanic/Latino backgrounds, which 
may partly explain the stronger effects, noted in that group. The statistical power to explore 
the pattern of effect modification however was insufficient for the other backgrounds. We 
found no evidence that sex modified the relationship between SA and PAD.
This study included a population-based, rather than a referral or clinic based sample, and 
thus is less influenced by selection biases than other cited research.54 Our Hispanic/Latinos 
US study population has long been recognized to have high obesity risk and is now 
documented to have high prevalence of SA.55 Prior studies evaluating the association 
between SA and subclinical peripheral atherosclerosis have not utilized the ABI, which is 
routinely available in a clinical setting and therefore is relatively accessible and at low cost. 
Finally, the methods of measurement of SA and PAD were objective and standardized as 
part of this large multi-center National Institutes of Health-sponsored cohort study.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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To our knowledge, this is the first study to assess the independent association between 
SA and PAD in a large community based cohort. We studied a diverse sample of 
Hispanics/Latinos, representing the largest American minority population, residing 
within the United States. We found that the presence of moderate to severe SA was 
associated with a 67% increase in the odds of PAD, as measured by the ABI. These 
findings are independent of age, sex, BMI, waist hip ratio, hypertension, CHD, diabetes, 
dyslipidemia, CRP levels, smoking, alcohol use, physical activity, study site, and 
Hispanic background is evident in both men and women. Furthermore we found that the 
strength of this association was modified by Hispanic/Latino group. Specifically the odds 
were stronger in Mexican and Puerto Rican Americans than in other backgrounds. Future 
studies are needed to address whether PAD improves with SA treatment. Further research 
may assess whether SA variably influences the atherosclerotic process in different 
vascular beds.
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Table 1






Age, years 56.0 (0.15) 60.7 (0.68) <0.0001
Females, % 54.7 (0.74) 67.4 (3.00) <0.0001
BMI, kg per m2 29.8 (0.09) 29.7 (0.46) 0.7800
Waist Circumference, cm 99.6 (0.21) 99.5 (1.01) 0.8597
Mean Waist to Hip Ratio 0.94 (0.00) 0.94 (0.00) 0.9063
Hypertension, % 41.3 (0.99) 63.9 (3.19) <0.0001
Prevalent CHD, % 9.44 (0.54) 18.3 (2.82) 0.0058
Diabetes, % 26.5 (0.79) 44.7 (3.40) <0.0001
Dyslipidemia, % 44.3 (0.85) 50.1 (3.66) 0.1218
Meet 2008 PA guidelines, % 58.9 (0.91) 51.0 (3.29) 0.0230
Mean log hsCRP Level 0.64 (0.02) 0.94 (0.07) <0.0001
Cigarette Pack-Years, % 0.0014
 Never Smoking 56.5 (0.90) 41.8 (3.76)
 0–10 18.3 (0.76) 18.1 (2.79)
 10 and plus 24.2 (0.89) 39.2 (3.88)
Alcohol use, % .0052
 Never 21.4 (0.88) 32.5 (3.76)
 Former 33.6 (0.92) 33.8 (3.47)
 Current 45.0 (0.86) 33.7 (3.28)
Hispanic/Latino Background, %
 Dominican 9.5 (0.77) 6.9 (1.51) <0.0001
 Central American 6.5 (0.43) 7.2 (1.48)
 Cuban 24.1 (1.95) 40.0 (4.22)
 Mexican Puerto 34.0 (1.77) 17.9 (3.22)
 Rican 18.1 (1.06) 20.7 (3.12)
 South American 5.43 (0.37) 5.0 (1.19)
 More than one/Other 2.27 (0.36) 2.54 (0.96)
AHI, events/hour 8.63 (0.23) 11.14 (1.25) 0.0466
Mean Lowest Oxygen Saturation (Minimum SpO2) 85.8 (0.12) 84.1 (0.62) 0.0062
Epworth Sleepiness Scale 5.9 (0.09) 5.7 (0.39) 0.6399
All values are weighted to account for the complex survey design. Standard errors in parenthesis.
PAD: Peripheral arterial disease; BMI: Body mass index; AHI: Apnea hypopnea index; CHD: coronary heart disease; PA: physical activity; 
hsCRP: highly sensitive C-reactive protein
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Table 2
Multivariable model assessing the relationship of moderate to severe SA (AHI≥15) and other clinical factors 
with PAD
Characteristic Odds Ratio 95% Confidence Interval P-value
Age (per year) 1.03 1.01–1.06 0.0144
Male (vs. female) 0.40 0.28–0.56 <0.0001
BMI (per unit) 0.93 0.89–0.96 0.0001
Waist hip ratio (per unit) 2.44 0.26–23.05 0.4372
Hypertension 1.58 1.10–2.26 0.0123
CHD 1.50 1.01–2.22 0.0465
Diabetes 1.60 1.05–2.45 0.0287
Dyslipidemia 0.93 0.67–1.29 0.6694
hsCRP (per mg/L) 1.12 1.04–1.19 0.0013
Pack-year of smoking: Less than 10 vs. Never 1.57 1.03–2.39 0.0341
Pack-year of smoking: 10+ vs Never 2.34 1.47–3.72 0.0003
Alcohol: Former vs. Never 1.00 0.59–1.68 0.9969
Alcohol: Current vs. Never 0.89 0.57–1.40 0.6083
Meet 2008 PA guidelines 1.05 0.77–1.43 0.7651
Moderate-to-severe SA (AHI >= 15, vs. AHI<15) 1.67 1.10–2.51 0.0152
Odds ratios are adjusted for all variables listed plus study site and Hispanic/Latino background.
SA: Sleep apnea; AHI: Apnea hypopnea index; PAD: Peripheral arterial disease; BMI: Body mass index; CHD: Coronary heart disease; hsCRP: 
highly sensitive C-reactive protein; PA: physical activity.
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Table 3
Relationship between Severity of SA and PAD
Severity of Sleep Apnea % PAD (95% CI) Odds Ratio (95% CI)
AHI < 5 (n=4432) 4.47 (3.57 – 5.60) Reference level
AHI 5–15 (n=1859) 4.37 (3.29 – 5.77) 0.97 (0.65 – 1.46)
AHI 15–30 (n=686) 7.88 (5.39 – 11.38) 1.90 (1.15 – 3.14)
AHI ≥ 30 (n=381) 5.32 (2.99 – 9.29) 1.21 (0.62 – 2.38)
Odds ratio is adjusted for: age, sex, study site, Hispanic/Latino background, education, income, BMI, pack years smoking, hypertension, CHD, 
diabetes, dyslipidemia, waist hip ratio, physical activity and hsCRP
SA: Sleep apnea; PAD: Peripheral arterial disease; AHI: Apnea hypopnea index; BMI: Body mass index; CHD: coronary heart disease; hsCRP: 
highly sensitive C-reactive protein
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